Fny Investment Advisers, LLC Biogen Inc. Transaction History

Fny Investment Advisers, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$256.56 - $292.34 $26,682 - $30,403	104 Added 104.0%	204 $56,000
Q4 2022 Jan 10, 2023	BUY	$252.44 - $306.72 $1,514 - $1,840	6 Added 6.38%	100 $27,000
Q3 2022 Oct 19, 2022	BUY	$194.69 - $268.46 $15,380 - $21,208	79 Added 526.67%	94 $25,000
Q1 2022 Apr 25, 2022	SELL	$193.77 - $244.14 $481,518 - $606,687	-2,485 Reduced 99.4%	15 $3,000
Q4 2021 Jan 10, 2022	BUY	$223.92 - $287.77 $559,800 - $719,425	2,500 New	2,500 $599,000
Q1 2021 Apr 12, 2021	SELL	$242.95 - $284.63 $1.21 Million - $1.42 Million	-5,000 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$236.26 - $355.63 $1.18 Million - $1.78 Million	5,000 New	5,000 $1.22 Million
Q4 2019 Jan 10, 2020	SELL	$220.06 - $304.07 $2,860 - $3,952	-13 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$217.44 - $243.88 $16,308 - $18,291	-75 Reduced 85.23%	13 $3,000
Q2 2019 Jul 24, 2019	BUY	$219.29 - $241.72 $19,297 - $21,271	88 New	88 $20,000
Q4 2018 Jan 22, 2019	SELL	$278.5 - $352.75 $7,798 - $9,877	-28 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $92,162 - $120,522	-314 Reduced 91.81%	28 $9,000
Q2 2018 Jul 18, 2018	BUY	$257.52 - $306.91 $88,071 - $104,963	342 New	342 $99,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.